Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.
Journal: Lancet (London, England)
Published: July 23, 2024
Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
Journal: Cancer research communications
Published: January 16, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Journal: American journal of hematology
Published: November 07, 2022
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.
Journal: Leukemia & lymphoma
Published: November 02, 2022
Secondary Central Nervous System Lymphoma: Updates in Treatment and Prophylaxis Strategies.
Journal: Current treatment options in oncology
Published: August 28, 2022
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Journal: American journal of hematology
Published: June 05, 2022
Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 18, 2022
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
Journal: Blood advances
Published: February 08, 2021
Last Updated: 09/26/2026